AS ONE Corporation (TYO:7476)
2,427.00
+43.50 (1.83%)
Mar 12, 2025, 3:30 PM JST
AS ONE Revenue
AS ONE had revenue of 26.74B JPY in the quarter ending December 31, 2024, with 8.99% growth. This brings the company's revenue in the last twelve months to 102.26B, up 8.61% year-over-year. In the fiscal year ending March 31, 2024, AS ONE had annual revenue of 95.54B with 4.50% growth.
Revenue (ttm)
102.26B
Revenue Growth
+8.61%
P/S Ratio
1.70
Revenue / Employee
143.82M
Employees
711
Market Cap
173.88B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 95.54B | 4.12B | 4.50% |
Mar 31, 2023 | 91.42B | 4.47B | 5.14% |
Mar 31, 2022 | 86.95B | 5.35B | 6.55% |
Mar 31, 2021 | 81.61B | 11.22B | 15.94% |
Mar 31, 2020 | 70.39B | 3.66B | 5.48% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,170.61B |
Takeda Pharmaceutical Company | 4,579.02B |
Daiichi Sankyo Company | 1,795.99B |
HOYA Corporation | 837.44B |
Terumo | 1,011.15B |
Otsuka Holdings | 2,329.86B |
Astellas Pharma | 1,867.63B |
Olympus | 993.33B |